Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Electra Therapeutics Inc.
Market Cap
$200.67M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$208.00M
Return on Assets (ROA)
18.34%
TTM Avg
16.50%
3Y Avg
12.68%
5Y Avg
11.55%
Market Cap
$193.67M
Return on Assets (ROA)
-78.16%
TTM Avg
-23.70%
3Y Avg
-68.26%
5Y Avg
-50.80%
Market Cap
$212.06M
Return on Assets (ROA)
-58.10%
TTM Avg
-37.08%
3Y Avg
-28.02%
5Y Avg
-25.91%
Market Cap
$214.85M
Return on Assets (ROA)
21.17%
TTM Avg
16.86%
3Y Avg
29.92%
5Y Avg
34.25%
Market Cap
$214.88M
Return on Assets (ROA)
15.00%
TTM Avg
14.43%
3Y Avg
-2.68%
5Y Avg
-18.26%
Market Cap
$215.11M
Return on Assets (ROA)
25.43%
TTM Avg
5.08%
3Y Avg
-10.27%
5Y Avg
-14.74%
Market Cap
$215.88M
Return on Assets (ROA)
-79.86%
TTM Avg
-75.29%
3Y Avg
-50.35%
5Y Avg
-41.02%
Market Cap
$189.45M
Return on Assets (ROA)
-44.41%
TTM Avg
-56.25%
3Y Avg
-49.77%
5Y Avg
-92.23%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $200.67M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $208.00M | 18.34% | 16.50% | 12.68% | 11.55% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $193.67M | -78.16% | -23.70% | -68.26% | -50.80% |
| Alector, Inc. (ALEC)vs › | $212.06M | -58.10% | -37.08% | -28.02% | -25.91% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.85M | 21.17% | 16.86% | 29.92% | 34.25% |
| Niagen Bioscience Inc (NAGE)vs › | $214.88M | 15.00% | 14.43% | -2.68% | -18.26% |
| Compugen Ltd. (CGEN)vs › | $215.11M | 25.43% | 5.08% | -10.27% | -14.74% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $215.88M | -79.86% | -75.29% | -50.35% | -41.02% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $189.45M | -44.41% | -56.25% | -49.77% | -92.23% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $217.48M | -31.94% | -71.44% | -59.77% | -50.19% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
